Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

Adam C. Seegmiller, MD, PhD, Annette S. Kim, MD, PhD, Claudio A. Mosse, MD, PhD, Mia A. Levy, MD, PhD, Mary Ann Thompson, MD, PhD, Megan K. Kressin, MD, Madan H. Jagasia, MD, Stephen A. Strickland, MD, MSCI, Nishitha M. Reddy, MD, Kristy J. Sinkfield, Samuel A. Santoro, MD, PhD, Mary M. Zutter, MD

Blood (2011) 118 (21): 2073.

https://doi.org/10.1182/blood.V118.21.2073.2073

Published: 2011

Journal Articles

Negative regulation of activated α2 integrins during thrombopoiesis

Zhiying Zou, Alec A. Schmaier, Lan Cheng, Patricia Mericko, S. Kent Dickeson, Thomas P. Stricker, Samuel A. Santoro, Mark L. Kahn

Blood (2009) 113 (25): 6428–6439.

https://doi.org/10.1182/blood-2008-08-175356

Published: 2009

Includes: Supplemental data

Journal Articles

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

A. M. Carella, E. Todisco, L. Castagna, A. Santoro, G. Catania, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano, R Varaldo

Blood (2008) 112 (11): 3294.

https://doi.org/10.1182/blood.V112.11.3294.3294

Published: 2008

Journal Articles

Novel collectin/C1q receptor mediates mast cell activation and innate immunity

Brian T. Edelson, Thomas P. Stricker, Zhengzhi Li, S. Kent Dickeson, Virginia L. Shepherd, Samuel A. Santoro, Mary M. Zutter

Blood (2006) 107 (1): 143–150.

https://doi.org/10.1182/blood-2005-06-2218

Published: 2006

Includes: Supplemental data

Journal Articles

HSV-TK Engineered Donor Lymphocytes Add-Backs Reduce Late Mortality and Improve Survival of High Risk Acute Leukemia after Haplo-HSCT: Results of a Phase II Multicenter Trial.

Blood (2005) 106 (11): 439.

https://doi.org/10.1182/blood.V106.11.439.439

Published: 2005

Journal Articles

GPVI and α 2 β 1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow

Kendra L. Sarratt, Hong Chen, Mary M. Zutter, Samuel A. Santoro, Daniel A. Hammer, Mark L. Kahn

Blood (2005) 106 (4): 1268–1277.

https://doi.org/10.1182/blood-2004-11-4434

Published: 2005

Includes: Supplemental data

Journal Articles

Clinical Impact of Q-RT-PCR Monitoring of Minimal Residual Disease in Newly Diagnosed Adult Patients with BCR-ABL+ Acute Lymphoblastic Leukemia Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PHD, G. Meloni, MD, L. Annino, MD, A. Chiarenza, MD, G. Martinelli, MD, F. Pane, MD, M. Montanaro, MD, P. Chiusolo, MD, A. Santoro, MD, M. Offidani, MD, M. Vignetti, MD, G. Saglio, MD, M. Baccarni, MD, F. Mandelli, MD, Robert Foa, MD

Blood (2004) 104 (11): 1082.

https://doi.org/10.1182/blood.V104.11.1082.1082

Published: 2004

Journal Articles

The contributions of the α 2 β 1 integrin to vascular thrombosis in vivo

Li He, Loretta K. Pappan, David G. Grenache, Zhengzhi Li, Douglas M. Tollefsen, Samuel A. Santoro, Mary M. Zutter

Blood (2003) 102 (10): 3652–3657.

https://doi.org/10.1182/blood-2003-04-1323

Published: 2003

Journal Articles

Location, location, location: targeting the endothelium

Samuel A. Santoro, Thomas P. Stricker

Blood (2003) 101 (10): 3761.

https://doi.org/10.1182/blood-2003-03-0764

Published: 2003

Journal Articles

Platelet Surface Collagen Receptor Polymorphisms: Variable Receptor Expression and Thrombotic/Hemorrhagic Risk

Samuel A. Santoro

Blood (1999) 93 (11): 3575–3577.

https://doi.org/10.1182/blood.V93.11.3575

Published: 1999

Journal Articles

Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease

P Valagussa, A Santoro, F Fossati Bellani, F Franchi, A Banfi, G Bonadonna

Blood (1982) 59 (3): 488–494.

https://doi.org/10.1182/blood.V59.3.488.488

Published: 1982

NARROW

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

Negative regulation of activated α2 integrins during thrombopoiesis

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

Novel collectin/C1q receptor mediates mast cell activation and innate immunity

HSV-TK Engineered Donor Lymphocytes Add-Backs Reduce Late Mortality and Improve Survival of High Risk Acute Leukemia after Haplo-HSCT: Results of a Phase II Multicenter Trial.

GPVI and α 2 β 1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow

Clinical Impact of Q-RT-PCR Monitoring of Minimal Residual Disease in Newly Diagnosed Adult Patients with BCR-ABL+ Acute Lymphoblastic Leukemia Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

The contributions of the α 2 β 1 integrin to vascular thrombosis in vivo

Location, location, location: targeting the endothelium

Platelet Surface Collagen Receptor Polymorphisms: Variable Receptor Expression and Thrombotic/Hemorrhagic Risk

Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only